Abstract:Importance Posttraumatic stress disorder (PTSD) is a common psychiatric disorder that is particularly difficult to treat in military veterans. Noninvasive brain stimulation has significant potential as a novel treatment to reduce PTSD symptoms. Objective To test whether active transcranial direct current stimulation (tDCS) plus virtual reality (VR) is superior to sham tDCS plus VR for warzone-related PTSD. Design, Setting, and Participants This double-blind randomized clinical trial was conducted among US military veterans enrolled from April 2018 to May 2023 at a secondary care Department of Veterans Affairs hospital and included 1- and 3-month follow-up visits. Participants included US military veterans with chronic PTSD and warzone-related exposure, recruited via referral and advertisement. Patients in psychiatric treatment had to be on a stable regimen for at least 6 weeks to be eligible for enrollment. Data were analyzed from May to September 2023. Intervention Participants were randomly assigned to receive 2-mA anodal tDCS or sham tDCS targeted to the ventromedial prefrontal cortex, during six 25-minute sessions of standardized warzone VR exposure, delivered over 2 to 3 weeks. Main Outcomes and Measures The co–primary outcomes were self-reported PTSD symptoms, measured via the PTSD checklist for DSM-5 (PCL-5), alongside quality of life. Other outcomes included psychophysiological arousal, clinician-assessed PTSD, depression, and social/occupational function. Results A total of 54 participants (mean [SD] age, 45.7 [10.5] years; 51 [94%] males) were assessed, including 26 in the active tDCS group and 28 in the sham tDCS group. Participants in the active tDCS group reported a superior reduction in self-reported PTSD symptom severity at 1 month ( t = −2.27, P = .02; Cohen d = −0.82). There were no significant differences in quality of life between active and sham tDCS groups. Active tDCS significantly accelerated psychophysiological habituation to VR events between sessions compared with sham tDCS ( F 5,7689.8 = 4.65; P &lt; .001). Adverse effects were consistent with the known safety profile of the corresponding interventions. Conclusions and Relevance These findings suggest that combined tDCS plus VR may be a promising strategy for PTSD reduction and underscore the innovative potential of these combined technologies. Trial Registration ClinicalTrials.gov Identifier: NCT03372460

What problem does this paper attempt to address?

### The problems the paper attempts to solve This paper aims to explore the effectiveness of the combination of virtual reality (VR) and transcranial direct current stimulation (tDCS) in treating post - traumatic stress disorder (PTSD) related to the war zone. Specifically, the goal of the study is to test whether using active tDCS in VR exposure therapy can significantly reduce PTSD symptoms, lower the arousal level of the autonomic nervous system, and improve social function more than using sham tDCS. ### Research background PTSD is a common mental illness, especially difficult to treat among military veterans. Non - invasive brain stimulation techniques, such as tDCS, are considered to have significant potential as new treatment methods to alleviate PTSD symptoms. tDCS applies a weak current through the scalp, which may help enhance neural activity in specific areas of the brain, thereby improving the processes of fear extinction and memory consolidation. And VR technology provides an immersive environment that can simulate war scenes for trauma - exposure therapy. ### Research design This double - blind, randomized controlled trial was conducted in a secondary - care hospital of the United States Department of Veterans Affairs. Participants were recruited from April 2018 to May 2023, and follow - up was carried out at 1 month and 3 months. Participants were randomly assigned to receive 2 mA anodal tDCS or sham tDCS, while undergoing six 25 - minute standard war - zone VR exposure therapies, with a treatment course lasting 2 to 3 weeks. ### Main results and measurement indicators The main outcome measures include: - Self - reported PTSD symptoms, evaluated by the "PTSD Checklist for DSM - 5" (PCL - 5). - Quality of life. Other outcome measures include: - Psychophysiological arousal level. - Physician - evaluated PTSD symptoms. - Depressive symptoms. - Social/occupational function. ### Results A total of 54 participants (average age 45.7 years, 94% male) were evaluated, among whom 26 received active tDCS treatment and 28 received sham tDCS treatment. The results showed that: - The self - reported PTSD symptom severity in the active tDCS group was significantly reduced at 1 month (t = - 2.27, P = 0.02; Cohen d = - 0.82). - The psychophysiological habituation speed between VR events in the active tDCS group was significantly faster (F5,7689.8 = 4.65, P < 0.001). - Adverse reactions were consistent with the known safety of the interventions. ### Conclusions These findings suggest that the combination of tDCS and VR may be a promising strategy for reducing PTSD symptoms, highlighting the innovative potential of these combined technologies.

Virtual Reality and Transcranial Direct Current Stimulation for Posttraumatic Stress Disorder